CIK 0000318154
- Large accelerated filer
AMGEN INC
Sign in to watch- Ticker
- AMGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 953540776
- Phone
- +1 805-447-1000
- Business address
- ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-07 | Busch Matthew C. VP, Finance & CAO | Grant or award | +730 | 5,080 | ||
| 2026-05-07 | Busch Matthew C. VP, Finance & CAO | Shares withheld for taxes | −41 | $331.11 | $14K | 4,344 |
| 2026-05-06 | Busch Matthew C. VP, Finance & CAO | Shares withheld for taxes | −50 | $329.59 | $16K | 4,385 |
| 2026-05-05 | Busch Matthew C. VP, Finance & CAO | Grant or award | +455 | 4,435 | ||
| 2026-05-05 | Busch Matthew C. VP, Finance & CAO | Grant or award · Nqso (Right to Buy) | +2,969 | $329.59 | $979K | 2,969 |
| 2026-05-02 | Busch Matthew C. VP, Finance & CAO | Shares withheld for taxes | −30 | $329.82 | $10K | 4,018 |
| 2026-05-02 | Busch Matthew C. VP, Finance & CAO | Shares withheld for taxes | −38 | $329.82 | $13K | 3,980 |
| 2026-03-16 | Busch Matthew C. VP, Finance & CAO | Shares withheld for taxes | −327 | $366.21 | $120K | 4,048 |
| 2026-03-03 | Busch Matthew C. VP, Finance & CAO | Grant or award | +938 | 4,361 | ||
| 2026-02-19 | Busch Matthew C. VP, Finance & CAO | Sale | −1,000 | $375.79 | $376K | 3,423 |
| 2025-11-05 | Busch Matthew C. VP, Finance & CAO | Shares withheld for taxes | −202 | $296.70 | $60K | 4,414 |
| 2025-05-06 | Busch Matthew C. VP, Finance & CAO | Grant or award | +554 | 4,588 | ||
| 2025-05-06 | Busch Matthew C. VP, Finance & CAO | Grant or award · Nqso (Right to Buy) | +3,585 | $270.44 | $970K | 3,585 |
| 2025-05-02 | Busch Matthew C. VP, Finance & CAO | Shares withheld for taxes | −28 | $283.78 | $8K | 5,071 |
| 2025-05-02 | Busch Matthew C. VP, Finance & CAO | Shares withheld for taxes | −37 | $283.78 | $10K | 5,034 |
| 2025-05-02 | Busch Matthew C. VP, Finance & CAO | Sale | −1,000 | $279.69 | $280K | 4,034 |
| 2025-04-30 | Busch Matthew C. VP, Finance & CAO | Shares withheld for taxes | −18 | $288.56 | $5K | 5,099 |
| 2025-03-17 | Busch Matthew C. VP, Finance & CAO | Shares withheld for taxes | −174 | $313.71 | $55K | 5,117 |
| 2025-03-03 | Busch Matthew C. VP, Finance & CAO | Grant or award | +497 | 5,277 | ||
| 2024-11-05 | Busch Matthew C. VP, Finance & CAO | Shares withheld for taxes | −189 | $316.91 | $60K | 4,770 |
Page 1 of 2 · 29 trades